Physician profile
Shu Yang
NPI 1588044259
$80,800.61
in general payments reported to CMS, 2019-2025
8 companies · $36K in 2025
The $36K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $885 · 2022: $521 · 2023: $23K · 2024: $20K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $35K · Consulting Fee: $33K · Travel and Lodging: $5,657 · Food and Beverage: $5,648 · Education: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $35,000.00 |
| Consulting Fee | $32,649.50 |
| Travel and Lodging | $5,657.29 |
| Food and Beverage | $5,648.06 |
| Education | $439.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $35,507.45 | 2021-2025 | Carto 3, Qdot Micro, Nuvision Ice Catheter |
| Medtronic, INC. | $20,621.94 | 2021-2025 | Micra, Affera Mapping System |
| Boston Scientific Corporation | $15,976.49 | 2021-2025 | Farapulse, S-Icd System Magnet, Watchman Access System |
| Abbott Laboratories | $3,577.08 | 2021-2025 | Aveir, Ensite, Gallant |
| Biotronik INC. | $2,912.39 | 2022-2023 | Sentus, Acticor 7 Vr-T Dx, Rivacor 7 Dr-T |
| Medical Device Business Services, INC. | $2,145.44 | 2024 | Carto 3 |
| Heartflow, INC. | $37.14 | 2024 | |
| Cordis US Corp. | $22.68 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shu Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.